Chemical Structure (Bleomycin 01)
Bleomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-0323
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 0409-0323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Bleomycin 02)
Principal Display Panel (30 unit Vial Label)
This is a description of a single-dose vial of Bleomycin for Injection, USP having NDC number 0409-0323-20 with a total volume of S5001ZTHZ. It is sterile and can be used intramuscularly, subcutaneously and intrapleurally but special handling procedures must be followed as it is cytotoxic. The manufacturer of the product is Novaplus™ which is a registered trademark of Vizent, Inc. The lot and identification numbers are not available.*
Principal Display Panel (30 unit Vial Carton)
This is a label of Bleomycin Sulfate, an injection used for Intravenous, Subcutaneous and other treatments. Each vial contains sterile Bleomycin sulfate equivalent to 30 units. Sulfuric acid or Sodium hydroxide may be used to adjust the pH levels. The instructions for dosage and precautions are enclosed. It must not be used after dilution; thus, it needs to be stored under refrigeration between 2°C to 8°C (36° to 46°F), and the unused portion should be discarded. The manufacturer is Hospira Inc., located in Lake Forest, IL USA, and distributed under Novaplus trademark.*
Principal Display Panel (15 unit Vial Label)
Principal Display Panel (15 unit Vial Carton)
This is a description of a vial of sterile Bleomycin Sulfate that contains 15 units of bleomycin. The pH may be adjusted using sulfuric acid or sodium hydroxide. The vial needs to be diluted and stored under refrigeration between 2 to 8 degree Celsius. The medication can be used for intravenous, intramuscular, subcutaneous and [GUETETIENVES]. The packaging of the medication includes instructions, dosage and precautions. The medication is distributed by Hospira, Inc, and Novaplus is a registered trademark of Vizent, Inc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
